Procurement, not patents, was the key to vaccine and antiviral development during the pandemic
While intellectual property played a role in building technology platforms, the real star incentive bringing vaccines and antivirals forward was public sector investment, most prominently procurement. Understanding this reality provides an opportunity for proactive planning before the next pandemic.